クローン病治療の世界市場レポート 2024年

クローン病治療市場規模は近年力強く成長しています。2023年の118億2,000万米ドルから2024年には126億米ドルへと、CAGR6.6％で拡大する見込みです。過去期間に見られた拡大は、疾病の蔓延の高まり、診断技術の進歩、生物学的療法の採用拡大、患者意識と教育の向上、臨床研究開発の進展など、いくつかの要因によるものです。

クローン病治療市場規模は、今後数年間で力強い成長が見込まれます。2028年には複合年間成長率（CAGR）6.7％で163億2,000万米ドルに成長します。予測期間中に予想される成長は、個別化医療アプローチの採用、生物製剤市場の拡大、治療ガイドラインの進化、医療支出の増加、共同研究努力などに起因すると考えられます。予測期間中に予想される重要な動向には、患者管理のための遠隔医療の利用、免疫調節戦略に関する進行中の調査、患者中心のケアモデルの導入、デジタルヘルスソリューションの統合などがあります。

クローン病治療市場の成長が期待される背景には、炎症性腸疾患の有病率の増加があります。これらの慢性疾患は消化管の炎症を伴い、口から肛門までのさまざまなセグメントに影響を及ぼします。クローン病治療は腸の炎症を抑え、症状の再燃を防ぎ、寛解を維持する上で重要な役割を果たしています。2020年4月に米国消化器病学会が実施した33カ国73,076人の成人回答者を対象とした世界の調査では、世界の40％以上の人が機能性胃腸障害（FGID）を経験しており、生活の質と医療利用の両方に影響を与えていることが明らかになった。炎症性腸疾患の有病率の上昇は、クローン病治療市場の重要な促進要因です。

クローン病治療市場の予測成長は、高齢化人口の増加によって促進されます。人口動態の変化により高齢者の割合が増加するにつれて、クローン病などの慢性疾患の有病率が上昇し、対応する治療法の需要が高まる。世界保健機関（WHO）の2022年10月の予測によると、2030年までに世界の6人に1人が60歳以上になるといいます。60歳以上の世界人口は2030年には14億人に達し、2050年には21億人に倍増すると予想されています。この人口動向は、クローン病治療市場の成長に大きく寄与します。

北米は、2023年のクローン病治療世界市場において最大の地域であり、予測期間においても急成長が見込まれる地域です。クローン病治療市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 市場促進要因・市場抑制要因
  • 市場促進要因
  • 市場抑制要因
• 市場規模と成長実績、2018～2023年
• 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のクローン病治療市場、薬剤の種類別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 抗生物質
• アミノサリシレート
• コルチコステロイド
• 免疫調節薬
• その他
• 世界のクローン病治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のクローン病治療市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 神経因性疼痛
• 線維筋痛症
• 慢性腰痛
• 関節痛
• 片頭痛術後疼痛
• がん性疼痛
• その他

第7章 地域および国の分析

• 世界のクローン病治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のクローン病治療市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• クローン病治療市場の競合情勢
• クローン病治療市場の企業プロファイル
  • AbbVie Inc.
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • Celgene Corporation
  • Eli Lilly and Company

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

“Crohn's Disease Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on crohn's disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for crohn's disease treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The crohn's disease treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Drug Type: Antibiotics; Amino Salicylates; Corticosteroids; Immunomodulators; Other Drug Types
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 3) By Application: Neuropathic Pain; Fibromyalgia; Chronic Back Pain; Arthritic Pain; Migraine Post-Operative Pain; Cancer Pain; Other Applications
• Companies Mentioned: AbbVie Inc.; AstraZeneca plc; Boehringer Ingelheim GmbH; Celgene Corporation; Eli Lilly and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Crohn's disease treatment encompasses medical interventions and therapies designed to manage Crohn's disease, a chronic gastrointestinal condition. The primary goals of treatment are to mitigate inflammation in the intestines, prevent symptom flare-ups, and sustain overall recovery.

The key drug categories in Crohn's disease treatment include antibiotics, aminosalicylates, corticosteroids, immunomodulators, and others. Antibiotics are pharmaceuticals utilized for both treating and preventing bacterial infections. These drugs are accessible through diverse channels, including hospital pharmacies, retail pharmacies, and online pharmacies. They find applications in various medical conditions such as neuropathic pain, fibromyalgia, chronic back pain, arthritic pain, migraine, post-operative pain, cancer pain, and other therapeutic areas.

The Crohn's disease treatment market research report is one of a series of new reports from The Business Research Company that provides Crohn's disease treatment market statistics, including Crohn's disease treatment industry global market size, regional shares, competitors with a Crohn's disease treatment market share, detailed Crohn's disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the Crohn's disease treatment industry. This Crohn's disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The crohn's disease treatment market size has grown strongly in recent years. It will grow from $11.82 billion in 2023 to $12.6 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%.The expansion observed during the historical period can be credited to several factors, including heightened disease prevalence, advancements in diagnostic techniques, increased adoption of biological therapies, improved patient awareness and education, and the progress in clinical research and development.

The crohn's disease treatment market size is expected to see strong growth in the next few years. It will grow to $16.32 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The anticipated growth in the forecast period can be attributed to the adoption of personalized medicine approaches, the expansion of the biologics market, the evolution of treatment guidelines, increased healthcare spending, and collaborative research efforts. Significant trends expected during the forecast period include the use of telemedicine for patient management, ongoing research on immune modulation strategies, the implementation of patient-centric care models, and the integration of digital health solutions.

The anticipated growth in the Crohn's disease treatment market is fueled by the increasing prevalence of inflammatory bowel disorders. These chronic conditions involve inflammation of the gastrointestinal tract, affecting various segments from the mouth to the anus. Crohn's disease treatment plays a crucial role in reducing intestinal inflammation, preventing symptom flare-ups, and maintaining remission. A global survey conducted by the American Gastroenterological Association in April 2020, covering 73,076 adult respondents across 33 countries, revealed that over 40% of individuals worldwide experience Functional Gastrointestinal Disorders (FGIDs), impacting both quality of life and healthcare utilization. The rising prevalence of inflammatory bowel disorders is a significant driver of the Crohn's disease treatment market.

The projected growth of the Crohn's disease treatment market is propelled by the rising aging population. As demographic shifts lead to an increased proportion of elderly individuals, the prevalence of chronic conditions such as Crohn's disease rises, driving demand for corresponding treatments. According to the World Health Organization's October 2022 projections, by the year 2030, one in six individuals globally will be 60 years old or older. The global population of individuals aged 60 and above is expected to reach 1.4 billion by 2030 and double to 2.1 billion by 2050. This demographic trend contributes significantly to the growth of the Crohn's disease treatment market.

A key trend gaining momentum in the Crohn's disease treatment market is product innovation. Major companies within the sector are dedicated to developing innovative products to enhance their market position. In May 2023, AbbVie Inc., a prominent US-based pharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for Rinvoq (upadacitinib), indicated for treating moderate to highly active Crohn's disease. Rinvoq's approval was based on efficacy and safety assessments in randomized induction studies (CD-1 and CD-2) involving 857 patients with moderately to highly active Crohn's disease.

Major companies in the Crohn's disease treatment market are directing efforts toward the development of new treatment options, including oral medications for moderate-severe Crohn's disease. In March 2022, AbbVie Inc. announced FDA approval for RINVOQ (upadacitinib), the first once-daily oral medication for patients with moderate-to-severe Crohn's disease. This selective Janus kinase (JAK) inhibitor precisely targets inflammation pathways, offering a potential reduction in adverse events linked to immunosuppression.

In March 2022, Pfizer Inc., a prominent US-based biopharmaceutical company, completed the acquisition of Arena Pharmaceuticals Inc. for approximately $6.7 billion. This strategic acquisition aimed to expand Pfizer's inflammation and immunology therapeutic area pipeline portfolio, encompassing conditions such as atopic dermatitis, eosinophilic esophagitis, ulcerative colitis, and Crohn's disease. Arena Pharmaceuticals Inc., a US-based biopharmaceutical company, significantly contributes to Pfizer's presence and offerings in the Crohn's disease treatment market.

Major companies operating in the crohn's disease treatment market report are AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Celgene Corporation, Eli Lilly and Company, Janssen Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Bristol-Myers Squibb Company, Galapagos NV, Gilead Sciences Inc., Novartis AG, Sanofi S.A., Union Chimique Belge, Astellas Pharma Inc., F. Hoffmann-La Roche Ltd., Vertex Pharmaceuticals Incorporated, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Regeneron Pharmaceuticals Inc., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Arena Pharmaceuticals Inc.

North America was the largest region in the global Crohn's disease treatment market in 2023, and is expected to be the fastest-growing region in the forecast period. The regions covered in the crohn's disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the crohn's disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The crohn's disease treatment market consists of sales of vedolizumab, methotrexate, and infliximab. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Crohn's Disease Treatment Market Characteristics

3. Crohn's Disease Treatment Market Trends And Strategies

4. Crohn's Disease Treatment Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Crohn's Disease Treatment Market Size and Growth

• 5.1. Global Crohn's Disease Treatment Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Crohn's Disease Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Crohn's Disease Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Crohn's Disease Treatment Market Segmentation

• 6.1. Global Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Antibiotics
• Amino Salicylates
• Corticosteroids
• Immunomodulators
• Other Drug Types
• 6.2. Global Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.3. Global Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Neuropathic Pain
• Fibromyalgia
• Chronic Back Pain
• Arthritic Pain
• Migraine Post-Operative Pain
• Cancer Pain
• Other Applications

7. Crohn's Disease Treatment Market Regional And Country Analysis

• 7.1. Global Crohn's Disease Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Crohn's Disease Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Crohn's Disease Treatment Market

• 8.1. Asia-Pacific Crohn's Disease Treatment Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Crohn's Disease Treatment Market

• 9.1. China Crohn's Disease Treatment Market Overview
• 9.2. China Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Crohn's Disease Treatment Market

• 10.1. India Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Crohn's Disease Treatment Market

• 11.1. Japan Crohn's Disease Treatment Market Overview
• 11.2. Japan Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Crohn's Disease Treatment Market

• 12.1. Australia Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Crohn's Disease Treatment Market

• 13.1. Indonesia Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Crohn's Disease Treatment Market

• 14.1. South Korea Crohn's Disease Treatment Market Overview
• 14.2. South Korea Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Crohn's Disease Treatment Market

• 15.1. Western Europe Crohn's Disease Treatment Market Overview
• 15.2. Western Europe Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Crohn's Disease Treatment Market

• 16.1. UK Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Crohn's Disease Treatment Market

• 17.1. Germany Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Crohn's Disease Treatment Market

• 18.1. France Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Crohn's Disease Treatment Market

• 19.1. Italy Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Crohn's Disease Treatment Market

• 20.1. Spain Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Crohn's Disease Treatment Market

• 21.1. Eastern Europe Crohn's Disease Treatment Market Overview
• 21.2. Eastern Europe Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Crohn's Disease Treatment Market

• 22.1. Russia Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Crohn's Disease Treatment Market

• 23.1. North America Crohn's Disease Treatment Market Overview
• 23.2. North America Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Crohn's Disease Treatment Market

• 24.1. USA Crohn's Disease Treatment Market Overview
• 24.2. USA Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Crohn's Disease Treatment Market

• 25.1. Canada Crohn's Disease Treatment Market Overview
• 25.2. Canada Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Crohn's Disease Treatment Market

• 26.1. South America Crohn's Disease Treatment Market Overview
• 26.2. South America Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Crohn's Disease Treatment Market

• 27.1. Brazil Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Crohn's Disease Treatment Market

• 28.1. Middle East Crohn's Disease Treatment Market Overview
• 28.2. Middle East Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Crohn's Disease Treatment Market

• 29.1. Africa Crohn's Disease Treatment Market Overview
• 29.2. Africa Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Crohn's Disease Treatment Market Competitive Landscape And Company Profiles

• 30.1. Crohn's Disease Treatment Market Competitive Landscape
• 30.2. Crohn's Disease Treatment Market Company Profiles
  • 30.2.1. AbbVie Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. AstraZeneca plc
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Boehringer Ingelheim GmbH
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Celgene Corporation
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Eli Lilly and Company
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Crohn's Disease Treatment Market Competitive Benchmarking

32. Global Crohn's Disease Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Crohn's Disease Treatment Market

34. Crohn's Disease Treatment Market Future Outlook and Potential Analysis

• 34.1 Crohn's Disease Treatment Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Crohn's Disease Treatment Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Crohn's Disease Treatment Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer